These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16247297)

  • 1. Fragile X syndrome: diagnostic and carrier testing.
    Sherman S; Pletcher BA; Driscoll DA
    Genet Med; 2005 Oct; 7(8):584-7. PubMed ID: 16247297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier screening in individuals of Ashkenazi Jewish descent.
    Gross SJ; Pletcher BA; Monaghan KG;
    Genet Med; 2008 Jan; 10(1):54-6. PubMed ID: 18197057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical standards and guidelines for reproductive screening in the Ashkenazi Jewish population.
    Monaghan KG; Feldman GL; Palomaki GE; Spector EB; ;
    Genet Med; 2008 Jan; 10(1):57-72. PubMed ID: 18197058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technical standards and guidelines: molecular genetic testing for ultra-rare disorders.
    Maddalena A; Bale S; Das S; Grody W; Richards S;
    Genet Med; 2005 Oct; 7(8):571-83. PubMed ID: 16247296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome editing in clinical genetics: points to consider-a statement of the American College of Medical Genetics and Genomics.
    Acmg Board Of Directors
    Genet Med; 2017 Jul; 19(7):723-724. PubMed ID: 28125080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American College of Medical Genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation.
    Shaffer LG;
    Genet Med; 2005; 7(9):650-4. PubMed ID: 16301868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations in healthcare reform for patients and families with genetic diseases: a statement of the American College of Medical Genetics and Genomics.
    Genet Med; 2018 Jun; 20(6):561. PubMed ID: 29388944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical standards and guidelines: venous thromboembolism (Factor V Leiden and prothrombin 20210G >A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratories.
    Spector EB; Grody WW; Matteson CJ; Palomaki GE; Bellissimo DB; Wolff DJ; Bradley LA; Prior TW; Feldman G; Popovich BW; Watson MS; Richards CS
    Genet Med; 2005; 7(6):444-53. PubMed ID: 16024978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct-to-consumer genetic testing: a revised position statement of the American College of Medical Genetics and Genomics.
    ACMG Board of Directors
    Genet Med; 2016 Feb; 18(2):207-8. PubMed ID: 26681314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics.
    ACMG Board of Directors
    Genet Med; 2015 Jun; 17(6):505-7. PubMed ID: 25764213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory and clinical genomic data sharing is crucial to improving genetic health care: a position statement of the American College of Medical Genetics and Genomics.
    Acmg Board Of Directors
    Genet Med; 2017 Jul; 19(7):721-722. PubMed ID: 28055021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scope of practice: a statement of the American College of Medical Genetics and Genomics (ACMG).
    ACMG Board of Directors
    Genet Med; 2015 Sep; 17(9):e3. PubMed ID: 26204421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory diagnosis of galactosemia: a technical standard and guideline of the American College of Medical Genetics and Genomics (ACMG).
    Pasquali M; Yu C; Coffee B
    Genet Med; 2018 Jan; 20(1):3-11. PubMed ID: 29261178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the adolescent or adult with some features of Marfan syndrome.
    Pyeritz RE;
    Genet Med; 2012 Jan; 14(1):171-7. PubMed ID: 22237449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic cytogenetic testing following positive noninvasive prenatal screening results: a clinical laboratory practice resource of the American College of Medical Genetics and Genomics (ACMG).
    Cherry AM; Akkari YM; Barr KM; Kearney HM; Rose NC; South ST; Tepperberg JH; Meck JM
    Genet Med; 2017 Aug; 19(8):845-850. PubMed ID: 28726804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.
    ACMG Board of Directors
    Genet Med; 2015 Jan; 17(1):68-9. PubMed ID: 25356965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Section E6.1-6.4 of the ACMG technical standards and guidelines: chromosome studies of neoplastic blood and bone marrow-acquired chromosomal abnormalities.
    Mikhail FM; Heerema NA; Rao KW; Burnside RD; Cherry AM; Cooley LD
    Genet Med; 2016 Jun; 18(6):635-42. PubMed ID: 27124785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Section E6.5-6.8 of the ACMG technical standards and guidelines: chromosome studies of lymph node and solid tumor-acquired chromosomal abnormalities.
    Cooley LD; Morton CC; Sanger WG; Saxe DF; Mikhail FM
    Genet Med; 2016 Jun; 18(6):643-8. PubMed ID: 27124786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acylcarnitine profile analysis.
    Rinaldo P; Cowan TM; Matern D
    Genet Med; 2008 Feb; 10(2):151-6. PubMed ID: 18281923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics.
    Strovel ET; Cowan TM; Scott AI; Wolf B
    Genet Med; 2017 Oct; 19(10):. PubMed ID: 28682309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.